We are live on ! Find out more
AWM

Aevitas Wealth Management Portfolio holdings

AUM $169M
1-Year Est. Return 9.55%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
-9.55%
3 Year Est. Return
+36.41%
5 Year Est. Return
+72.53%
10 Year Est. Return
–
AUM
$110M
AUM Growth
+$7.71M
Cap. Flow
+$1.15M
Cap. Flow %
1.05%
Top 10 Hldgs %
29.89%
Holding
461
New
33
Increased
162
Reduced
63
Closed
7

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$511K
2
VTV icon
Vanguard Value ETF
VTV
+$489K
3
PEP icon
PepsiCo
PEP
+$236K
4
VB icon
Vanguard Small-Cap ETF
VB
+$129K
5
NVDA icon
NVIDIA
NVDA
+$78K

Top Sells

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$262K
2
VYGR icon
Voyager Therapeutics
VYGR
+$211K
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$188K
4
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
+$161K
5
BSCM
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
+$92.7K

Sector Composition

Rank Sector Weight
1 Healthcare 12.78%
2 Technology 12.74%
3 Consumer Staples 11.44%
4 Consumer Discretionary 8.84%
5 Financials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRVL icon
426
Marvell Technology
MRVL
$157B
$2K ﹤0.01%
+108
New +$2.22K
EQC
427
DELISTED
Equity Commonwealth
EQC
$2K ﹤0.01%
75
– –
SIOX
428
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2K ﹤0.01%
81
– –
BAC.WS.B
429
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$2K ﹤0.01%
5,600
– –
AWF
430
AllianceBernstein Global High Income Fund
AWF
$871M
$1K ﹤0.01%
97
– –
BHF icon
431
Brighthouse Financial
BHF
$3.66B
$1K ﹤0.01%
13
– –
DHC
432
Diversified Healthcare Trust
DHC
$2.28B
$1K ﹤0.01%
30
– –
DOV icon
433
Dover
DOV
$27.4B
$1K ﹤0.01%
10
– –
EPC icon
434
Edgewell Personal Care
EPC
$1.3B
$1K ﹤0.01%
17
– –
HQL
435
abrdn Life Sciences Investors
HQL
$589M
$1K ﹤0.01%
35
– –
ISRG icon
436
Intuitive Surgical
ISRG
$130B
$1K ﹤0.01%
+3
New +$533
LUMN icon
437
Lumen
LUMN
$6.38B
$1K ﹤0.01%
55
– –
NVT icon
438
nVent Electric
NVT
$22.9B
$1K ﹤0.01%
20
– –
PCAR icon
439
PACCAR
PCAR
$72.7B
$1K ﹤0.01%
29
– –
PNR icon
440
Pentair
PNR
$10.8B
$1K ﹤0.01%
20
– –
PYPL icon
441
PayPal
PYPL
$50.3B
$1K ﹤0.01%
+6
New +$528
RUN icon
442
Sunrun
RUN
$2.3B
$1K ﹤0.01%
+100
New +$1.38K
SWKS icon
443
Skyworks Solutions
SWKS
$9.73B
$1K ﹤0.01%
12
– –
TMO icon
444
Thermo Fisher Scientific
TMO
$214B
$1K ﹤0.01%
4
-100
-96% -$23K
TRV icon
445
Travelers Companies
TRV
$82.9B
$1K ﹤0.01%
10
– –
UNIT
446
Uniti Group
UNIT
$2.53B
$1K ﹤0.01%
35
– –
VGK icon
447
Vanguard FTSE Europe ETF
VGK
$30.2B
$1K ﹤0.01%
20
– –
VOD icon
448
Vodafone
VOD
$37.7B
$1K ﹤0.01%
35
+2
+6% +$46
VYX icon
449
NCR Voyix
VYX
$1.19B
$1K ﹤0.01%
36
– –
DUC
450
DELISTED
Duff & Phelps Utility & Corporate Bond Trust
DUC
$1K ﹤0.01%
150
– –
15 16 17
18
19

Similar funds

CCM
Cribstone Capital Management Augusta, Maine $172M AUM 13.58% 1-Year Est. Return
BA
Bennicas & Associates Portola Valley, California $173M AUM 1.55% 1-Year Est. Return
BFS
Bickling Financial Services Lexington, Massachusetts $160M AUM 18.81% 1-Year Est. Return
RCC
Red Cedar Capital Omaha, Nebraska $158M AUM 6.57% 1-Year Est. Return
S
Schroders London, United Kingdom $185M AUM 16.04% 1-Year Est. Return
RCA
Rex Capital Advisors Providence, Rhode Island $152M AUM 17.51% 1-Year Est. Return
SCM
Snowhook Capital Management New York $187M AUM 31.24% 1-Year Est. Return
WWA
WC Walker & Associates Fullerton, California $189M AUM 16.91% 1-Year Est. Return

Aevitas Wealth Management's Q3 2018 Portfolio in Review

As of Q3 2018, Aevitas Wealth Management held 461 positions worth $110M, up 7.5% from $103M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Aevitas Wealth Management's Q3 2018 filing shows 33 new, 162 increased, 63 reduced and 7 closed positions. Its largest new stake was Weyerhaeuser: 1,110 shares worth $36K. The largest sale was CRISPR Therapeutics, an estimated $262K.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Staples.

  • Aevitas Wealth Management's largest Q3 2018 buy was Weyerhaeuser: 1,110 shares worth $36K.
  • Aevitas Wealth Management added most to Microsoft in Q3 2018, an estimated $511K increase.
  • Aevitas Wealth Management's biggest Q3 2018 reduction was CRISPR Therapeutics, cutting an estimated $262K.
  • Aevitas Wealth Management fully exited Wgl Holdings in Q3 2018, selling an estimated $71K.
  • Aevitas Wealth Management's ten largest holdings make up 30% of its $110M portfolio in Q3 2018.
  • Aevitas Wealth Management opened 33 new positions and closed 7 in Q3 2018.
  • Aevitas Wealth Management's portfolio value rose 7.5% quarter-over-quarter to $110M.

Based on Aevitas Wealth Management's 13F filing for Q3 2018, filed 14 Nov 2018.